CVE-2026-106511CVE-2026-106511
Updated under an hour ago ()
Does this affect you?
It affects MultiversX Labs S.R.L. multisig-improved. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.38%, higher than 30% of scored CVEs.
Do this next
Free account, 1 product
MultiversX's multisig-improved (repository: mx-multisig-and-modules) reference implementation of their on-chain multisig smart contract system contains a vulnerability where a missing independent authorization check allows any account with the Proposer role to perform explicitly barred actions. This vulnerability allows the Proposer role to move funds alone, draining 100% of a contract's EGLD/ESDT balance in two transactions with zero signatures.
- CVSS
- 9.8 CRITICAL (v3.1, CISA ADP)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-862, CWE-863, CWE-306
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.38% (percentile 30)
- Assigned by
- certcc
- NVD analysis
- Deferred
- Record last updated
- Oct 7, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
MultiversX Labs S.R.L. multisig-improved multiversx_labs_s.r.l:multisig_improved (from the name) | GitHub commit 2e6dbea40f9b8ac165572a9efd4304804762a299 | CNA record |
References
- https://github.com/multiversx/mx-multisig-and-modules
- https://gist.github.com/x01griax/c03f4be898dc55ccf3bab667c83c7312
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.